期刊文献+

光学药物压抑疗法治疗儿童中度弱视124例临床研究 被引量:6

OPTICAL AND PHARMACOLOGICAL PENALIZATION FOR TREATMENT OF MODERATE AMBLYOPIA IN CHILDHOOD
下载PDF
导出
摘要 目的研究光学药物压抑疗法治疗儿童中度弱视临床疗效。方法选取248例符合研究条件的中度弱视儿童,随机分成遮盖治疗组和光学药物压抑治疗组,每组124例。遮盖治疗组弱视眼配镜,健眼每天遮盖8h以上;光学药物压抑治疗组弱视眼配适矫镜,健眼用1%阿托品眼药水或眼药膏点眼,每周一次,戴欠矫+5.0DS镜片。结果对所有病例均进行1年以上随访,遮盖治疗组和光学药物压抑治疗组疗效差异无统计学意义(P>0.05)。在治疗的前2个月遮盖组疗效明显;年龄与弱视类型不是影响疗效的因素。5岁以上患者压抑治疗好于遮盖治疗,但差异无统计学意义。结论光学药物压抑疗法与遮盖疗法治疗儿童中度弱视具有同等疗效,而且还具有依从性好,不影响外观,不易出现遮盖性弱视等优点,应该广泛开展应用。 Objective To combine optical and atropine penalization treatment (COAT), and assessed it in children with moderate amblyopia. Methods 248 children with moderate amblyopia were selected and divided into 2 groups at random. Children in group Ⅰ (124 cases) wore full corrected glasses with the amblyopic eye and occlusion with the sound one. Children in group Ⅱ (124cases) were prescribed weekly 1% atropine drop or ointment and + 5DS glasses to the sound eye while the amblyopic one wore full corrected glasses, Results There was no significant difference in efficacy between the two groups at a follow - up of more than 1 year. Patients in the occluding group had a better improvement in the first two months. Age and types of amblyopia were not related to the effect. Effect of children elder than 5 year- old showed a greater improvement in the penalization group than those in the occluding one(P〉0.05). Conclusion Optical and pharmacological penalization show a similar effect with occlusion therapy in the treatment of moderate children amblyopia with a low risk of occlusion amblyopia. Penalization should be considered more often for the primary treatment of amblyopia.
出处 《中国煤炭工业医学杂志》 2007年第8期878-880,共3页 Chinese Journal of Coal Industry Medicine
关键词 光学 压抑疗法 弱视 optical pharmacological penalization amblyopia
  • 相关文献

参考文献9

  • 1甘晓玲.弱视的定义、分类及疗效评价标准[J].中国斜视与小儿眼科杂志,1996,4(3):97-97. 被引量:1013
  • 2李凤鸣.眼科全书[M].北京:人民卫生出版社,1996.2575.
  • 3Kaye SB,Chen SI,Price G,et al.Combined optical and atropine penalization for the treatment of strabismic and anisometropic amblyopia[J].J AAPOS,2002,6(5):289-293
  • 4North RV,Kelly ME.Atropine occlusion in the treatment of strabismic amblyopia and trs effect on the non-amblyopic eye[J].Ophthalmic Physiol Opt,1991,11(1):113
  • 5Hussein MA,Coats DK,Muthialu A,et al.Risk factor for treatment failure of anisometropic amblyopia[J].J AAPOS,2004,8(5):429-434
  • 6Mazow ML,Chuang A,Vital MC,et al.1999 Costenbader Leeture.Outcome study in amblyopia;treatment and practice pattern variations[J].J AAPOS,2000,4(1):1-9
  • 7Leiba H,Shimshoni M,Oliver M,et al.Long-trem follow-up of occlusion therapy in amblyopia[J].Ophthaimology,2001,108:1552
  • 8Repka MX,Cotte SA,Beck RW,et al.A randomized trial of atropine regimens for treatment moderate amblyopia in children[J].Ophthalmology,2004,111(11):2076-2085
  • 9Simons K,Stein L,Sener EC,et al.Full time atropine,intermittent atropine,and optical penalization and binocular outcome in treatment of strabismic amblyopia[J].Ophthalmology,1997,104(12):2143-2155

共引文献2485

同被引文献58

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部